Search images on Google      Product Monograph

Active Ingredients:

• fludeoxyglucose 18f, 0.5 GBQ/VIAL

DIN: 02433230

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Schedule C

Company: BC CANCER, PART OF THE PROVINCIAL HEALTH SERVICES AUTHORITY

ATC:

• V09 - DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, WHO, Wiki)
• V09I - TUMOUR DETECTION (ATC, WHO)
• V09IX - Other diagnostic radiopharmaceuticals for tumour detection (ATC, WHO)
• V09IX04 - FLUDEOXYGLUCOSE (18F) (WHO)

 

External Links for Fludeoxyglucose (18F) Injection:

Search on Google

• Fludeoxyglucose (18F) Injection side effects
• Fludeoxyglucose (18F) Injection dosage
• fludeoxyglucose 18f side effects
• fludeoxyglucose 18f dosage